The 3 Junior Biotech to Watch Out for in 2017
Despite the broader sector of the market underperforming in comparison to other market groups, investors are continuing to test the waters of junior biotech. In 2016, there was a massive attack on industry price fixing …
Amgen Submits Applications for Repatha to U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA)
Multinational biopharmaceutical company Amgen ($AMGN) has recently announced its submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) as well as request for marketing authorization to the European …
Kite Pharma, Inc. Set to Present at Two Investor Conferences in June 2017
On June 6, 2017, Kite Pharma, Inc., (NASDAQ:$KITE), which is a prominent cell therapy company headquartered in Santa Monica, announced that they will be presenting at two investor conferences in June 2017.
The conferences … Read
President and CEO of VBI Vaccines Set to Present at Jefferies 2017 Global Healthcare Conference
VBI Vaccines Inc. (NASDAQ:$VBIV), a biopharmaceutical company headquartered in Cambridge, MA, announced today that VBI’s President and CEO, Jeff Baxter, will be presenting at the Jefferies 2017 Global Healthcare Conference on Friday, June 9, 2017 …
Pomerantz Law Firm Launches Class Action Lawsuit Against Lion Biotechnologies, Inc.
New York City-based law firm, Pomerantz LLP, has just announced that a class action lawsuit has been filed against Lion Biotechnologies, Inc. (LBIO) (NASDAQ:$IOVA) and certain of its officers. The lawsuit was filed in United …
3 Biotech Stocks You Should Add to Your Investing Portfolio for 2017
For those looking to add to their investing portfolio, you might want to consider investing in biotech stocks. Generally speaking, most investors will avoid biotech stocks because they think that there is too much risk …